ZoomInfo Technologies (GTM) Could Be 69% Undervalued After Its DemandScience Partnership

ZoomInfo Technologies (GTM) drew fresh attention on July 29, 2026, after DemandScience announced a new partnership that links its marketing outcomes data and multi channel demand generation services with ZoomInfo's data platform.

See our latest analysis for ZoomInfo Technologies.

The partnership news has arrived during a sharp near term rebound for ZoomInfo Technologies. The 7 day share price return of 19.86% matches its 30 day share price return. This comes against a year to date share price return that is down 63.58% and a 5 year total shareholder return that is down 94.22%. Taken together, these figures point to improving short term momentum following a very weak longer term record.

If this kind of data focused story has your attention, it could be a useful moment to look wider and scan 56 AI infrastructure stocks as potential next research candidates.

After ZoomInfo Technologies jumped 19.86% in a week yet remains deeply down over one and five years, the real tension is clear. Has most of the easy rebound already played out, or does valuation still leave meaningful upside?

Advertisement

Most Popular Narrative: 68.6% Undervalued

At a last close of $3.50 compared with a narrative fair value of $11.15, ZoomInfo Technologies sits at the center of a sharp valuation gap that bullish analysts try to explain in detail.

The accelerating adoption of advanced AI-powered features such as Copilot and operations solutions is unlocking higher value use cases for enterprise customers, driving strong upsell momentum and expansion into new user personas. This broader product adoption raises average contract values and supports top-line revenue growth through both new customer wins and deeper penetration within existing accounts.

Read the complete narrative.

Want to understand why this narrative still supports a much higher price for ZoomInfo Technologies? The story hinges on future margins, earnings power, and the multiple the market might be willing to pay. The specific mix of revenue trends, profitability shifts, and valuation assumptions is where the real debate starts.

Result: Fair Value of $11.15 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, ZoomInfo Technologies still faces real pressure from tighter privacy rules and clients building in house data solutions, either of which could undercut the bullish margin story.

Find out about the key risks to this ZoomInfo Technologies narrative.

Next Steps

With ZoomInfo Technologies caught between clear risks and real potential rewards, it makes sense to move quickly and test the numbers yourself. You can weigh both sides in detail by reviewing the 4 key rewards and 2 important warning signs

Looking for more investment ideas beyond ZoomInfo Technologies?

If you are serious about building a stronger portfolio, do not stop with ZoomInfo Technologies. Use the Simply Wall St screener to spot opportunities other investors might overlook.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if ZoomInfo Technologies might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGS:GTM

ZoomInfo Technologies

Provides go-to-market intelligence and engagement platform for sales, marketing, operations, and recruiting professionals in the United States and internationally.

Undervalued with solid track record.

Advertisement

Weekly Picks

CE
Ceazar
SPAI logo
Ceazar on Sparc AI ·

When GPS fails: this small cap is fixing a $54B drone problem

Fair Value:CA$5.2554.7% undervalued
107 users have followed this narrative
0 users have commented on this narrative
23 users have liked this narrative
BL
BlackGoat
IREN logo
BlackGoat on IREN ·

IREN's Bold Moves in Sustainable Bitcoin Mining & AI Data Centers

Fair Value:US$71.4859.0% undervalued
213 users have followed this narrative
8 users have commented on this narrative
32 users have liked this narrative
HE
HedgeY
ARM logo
HedgeY on Arm Holdings ·

The Architecture Layer of AI Computing - But Priced Like the Future Already Arrived?

Fair Value:US$43047.7% undervalued
20 users have followed this narrative
1 users have commented on this narrative
6 users have liked this narrative
HI
Hidden_Rock_Capital
FISV logo
Hidden_Rock_Capital on Fiserv ·

Temporary "perfect storm" leads to opportunity to buy financial services leader for less than 5x long-term earnings

Fair Value:US$119.9953.6% undervalued
25 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative

Updated Narratives

SI
MSFT logo
simplydunno on Microsoft ·

Microsoft's Capex Bill Comes Due Before the AI Revenue Does

Fair Value:US$512.123.7% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
HE
NGXGROUP logo
Henrynuke03 on Nigerian Exchange Group ·

Future Growth Awaits NGXGROUP with New High-Profile Listings

Fair Value:₦221.1732.3% undervalued
7 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
PR
PrashhD
AURIONPRO logo
PrashhD on Aurionpro Solutions ·

Aurionpro Solutions: Is the Market Mispricing One of India's Most Interesting Fintech Product Companies?

Fair Value:₹1k27.1% undervalued
1 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28032.1% undervalued
211 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.917.0% undervalued
97 users have followed this narrative
0 users have commented on this narrative
7 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6510.2% undervalued
74 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0
VI
533581 logo
vijay_kant_fobiu on PG Electroplast ·

products

0
|
0